Navigation Links
CCNY researchers study scientific collaboration in age of internet
Date:10/15/2009

Collaboration has long been recognized as essential to the advancement of scientific knowledge. While the nature of co-production of knowledge in collaborative settings has been studied for some time, little is known about how the process works in collaborations established and maintained through virtual organizations.

An interdisciplinary team of researchers at The City College of New York (CCNY) is studying how virtual organizations, where people work in different locations, sometime halfway around the world, change and affect the production of scientific knowledge. They are supported by a new grant from the National Science Foundation (NSF) of $368,210 over three years. The investigators hope to identify the conditions under which virtual organizations can enable and enhance scientific production and innovation.

"It used to be that collaboration took place mainly within one laboratory, but now you can collaborate with people you don't even know, said Dr. Maria Binz-Scharf, Assistant Professor of Management in the Economics Department at CCNY and Principal Investigator of the project. "The question is: How does greater access to shared data, new collaborators and information across time and space help improve the production of scientific knowledge, if at all?"

The CCNY team includes, in addition to Professor Binz-Scharf, Dr. Leslie Paik, Assistant Professor of Sociology and the project's co-Principal Investigator, and Dr. Avrom Caplan, Professor of Biology and Associate University Dean for Research. They will focus their research on biologists, Dean Caplan among them, who study molecular chaperones, which are proteins that are part of a process called cellular quality control that promotes destruction of damaged proteins.

"It's a fairly well-defined area with around active 300 researchers worldwide, so it is an ideal network to study," Professor Binz-Scharf explained.

The investigation is being conducted in
'/>"/>

Contact: Ellis Simon
esimon@ccny.cuny.edu
212-650-6460
City College of New York
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Researchers identify proteins involved in new neurodegenerative syndrome
2. Texas researchers and educators head for Antarctica
3. MGH researchers describe new way to identify, evolve novel enzymes
4. University of Pennsylvania researchers develop formula to gauge risk of disease clusters
5. U of MN researchers discover noninvasive diagnostic tool for brain diseases
6. U of Minnesota researchers discover noninvasive diagnostic tool for brain diseases
7. Researchers discover new strategies for antibiotic resistance
8. Researchers find new taste in fruit flies: carbonated water
9. Binghamton University researchers investigate evolving malaria resistance
10. UIC researchers find promising new targets for antibiotics
11. Researchers develop simple method to create natural drug products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...h Centre, a partnership of the University of Briti...tal Health Research Institute, have uncovered new ...ls die following a stroke, as well as a possible w...dy were recently published online in Nature Medic...tinue to die even after blood flow has been restor...
(Date:11/20/2009)...ad studies about the health benefits of having a l...ar level, where amino acids known as cysteines are...hen paired up with other cysteines. , Now, resea...olleagues in Belgium, have discovered a new antiox...esearch appears in the Nov. 20 issue of the journa...
(Date:11/20/2009)...9) Scientists from the Marine Biogeochemistry and...arch Laboratory (NRL) organized and led a team of ...expedition to initiate methane hydrate exploration...iation of sediment contribution to Arctic climate ...Polar Sea as a research platform, three cross-shel...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 1100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 2100+ Nurses to Rally in SF Wed to Demand Stronger Swine Flu Safety Protections 3A California Hospitals Remain Unprepared Despite First Nurse Death 53680 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 1ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 2ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 3ViroPharma Announces Support by Advisory Committee of The Office of Generic Drugs Proposed Guidelines for Developing Generic Versions of Oral Vancomyc 53677 4Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 1Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 2Premier of Split Estate at DocuWeeks 2009 to Call National Attention to Urban Drilling in New York and Los Angeles 53675 3
...dentified the proteins that allow specific brain c...aks what can come into the cell. The findings, des...researchers harness the process, perhaps one day u...disease. , Much as turning the television dial cha...cells are able to change what they allow in by swa...
...eaded by Professor Hans-Georg Kräusslich at Heidel...Hanswalter Zentgraf, Division of Applied Tumor Vir...man Cancer Research Center, DKFZ), have been the f... for visual investigations without inhibiting the ...beling permits scientists to observe the behavior ...
... secreted by mussels and a polymer that repels cel...rsity have designed a versatile new two-sided coat... , Currently the longevity of certain medical imp... in the body gradually accumulate on the devices (...and threatening patients with infections. Unfortun...
Other Biology News:Some Brain Cells Change Channels 2Some Brain Cells Change Channels 3New Species of Coral Discovered Off Southern California 2Innovative coating could give medical implants a longer life 2
(Date:11/20/2009)...ntly announced that Dr. Dominique Hebrault will pr...nalytical Technology (PAT) in Green Chemistry and ... (PRWEB) November 20, 2009 -...ology (PAT) in Green Chemistry and Green Engineeri...nology (PAT) case studies will be presented on how...
(Date:11/19/2009)...Call/ -- Omeros Corporation (Nasdaq: OMER ) today...rd quarter ended September 30, 2009. For the three...a net loss of $3.9 million, or $1.34 per share, as...per share, for the same period in 2008. For the ni...ported a net loss of $15.5 million, or $5.29 per s...
(Date:11/19/2009)...tCall/ -- NeoStem, Inc. (NYSE Amex: NBS ), announ... its shareholders, discussing the Company,s acquis...icals Holdings, Inc. (CHBP), an integrated bio-pha... of China. The merger gives NeoStem a controlling ...., CHBP,s primary operating subsidiary and a promi...
(Date:11/19/2009)...19 MONITORING FORCE GmbH,announced...nserin in the,indication treatment-relevant levodo...rphan drug status designation with the European Me... is a complication of the mainstay,treatment in ad... those,affected, since it may be disabling for the...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
... TSX Exchange Symbol: RVX, CALGARY, Apri...Resverlogix" or the "Company") (TSX:RVX) announced...a safety, tolerability and pharmacokinetics,study ...ses the,dyslipidemia market. "Initial results from... J. McCaffrey, President & CEO of Resverlogix. "As...
...SM), a developer of follow-on biologics (FOBs) and...Allan, Ph.D., CEO of Insmed, will present at,the C...n FOBs, on April 29,2008 at 2:15 PM Eastern Time i..."Evaluate the Legislative, Economic and,Scientific...rs and,Follow-On Biologics," will be held at the D...
...oterrorism, Says UK Board Mem...fense Corp., the only company in,the world to deve...destroy,a biohazardous substance while maintaining...ounced it has partnered with General Lord Guthrie,...blish new security,markets for the BioDefense Mail...
Other Biology Technology:Dosing for RVX-208 Phase 1a Clinical Study Completed 2Insmed to Present at CBI Follow-On Biologics Conference 2Insmed to Present at CBI Follow-On Biologics Conference 3Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 2Boston-Based BioDefense Corp. Announces New UK Partnership to Expand Markets for Biohazard Protection 3
Cryopreservation medium, preadipocytes from Zen-Bio, Inc.
5X MEGAscript® T7 Kit from Ambion
Mouse Anti-Rad 51C Monoclonal Antibody, Unconjugated, Clone 2H11/6 from ABR-Affinity BioReagents
Flexi Rabbit Reticulocyte Lysate System from Promega
Biology Products: